Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Nurix Therapeutics (NRIX) Gross Profit: 2019-2024

Historic Gross Profit for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $54.5 million.

  • Nurix Therapeutics' Gross Profit fell 37.29% to $7.9 million in Q3 2025 from the same period last year, while for Aug 2025 it was $83.7 million, marking a year-over-year increase of 48.32%. This contributed to the annual value of $54.5 million for FY2024, which is 29.15% down from last year.
  • Latest data reveals that Nurix Therapeutics reported Gross Profit of $54.5 million as of FY2024, which was down 29.15% from $77.0 million recorded in FY2023.
  • Nurix Therapeutics' 5-year Gross Profit high stood at $77.0 million for FY2023, and its period low was $17.8 million during FY2020.
  • Moreover, its 3-year median value for Gross Profit was $54.5 million (2024), whereas its average is $56.7 million.
  • In the last 5 years, Nurix Therapeutics' Gross Profit crashed by 42.73% in 2020 and then soared by 99.31% in 2023.
  • Over the past 5 years, Nurix Therapeutics' Gross Profit (Yearly) stood at $17.8 million in 2020, then skyrocketed by 66.95% to $29.8 million in 2021, then rose by 29.84% to $38.6 million in 2022, then soared by 99.31% to $77.0 million in 2023, then dropped by 29.15% to $54.5 million in 2024.